195 related articles for article (PubMed ID: 31567539)
1. Mutational Profile in Vulvar, Vaginal, and Urethral Melanomas: Review of 37 Cases With Focus on Primary Tumor Site.
Zarei S; Voss JS; Jin L; Jenkins SM; Bryce AH; Erickson LA; Bell DA; Kipp BR; Flotte TJ
Int J Gynecol Pathol; 2020 Nov; 39(6):587-594. PubMed ID: 31567539
[TBL] [Abstract][Full Text] [Related]
2. Malignant Melanoma of Vulva and Vagina: A Histomorphological Review and Mutation Analysis--A Single-Center Study.
Rouzbahman M; Kamel-Reid S; Al Habeeb A; Butler M; Dodge J; Laframboise S; Murphy J; Rasty G; Ghazarian D
J Low Genit Tract Dis; 2015 Oct; 19(4):350-3. PubMed ID: 26225944
[TBL] [Abstract][Full Text] [Related]
3. Vulvar and vaginal melanoma: A unique subclass of mucosal melanoma based on a comprehensive molecular analysis of 51 cases compared with 2253 cases of nongynecologic melanoma.
Hou JY; Baptiste C; Hombalegowda RB; Tergas AI; Feldman R; Jones NL; Chatterjee-Paer S; Bus-Kwolfski A; Wright JD; Burke WM
Cancer; 2017 Apr; 123(8):1333-1344. PubMed ID: 28026870
[TBL] [Abstract][Full Text] [Related]
4. Comparison of molecular abnormalities in vulvar and vaginal melanomas.
Aulmann S; Sinn HP; Penzel R; Gilks CB; Schott S; Hassel JC; Schmidt D; Kommoss F; Schirmacher P; Kommoss S
Mod Pathol; 2014 Oct; 27(10):1386-93. PubMed ID: 24603591
[TBL] [Abstract][Full Text] [Related]
5. BRAF mutations might be more common than supposed in vulvar melanomas.
Wylomanski S; Denis MG; Théoleyre S; Bouquin R; Vallée A; Knol AC; Saint-Jean M; Peuvrel L; Dréno B; Quéreux G
Exp Dermatol; 2018 Feb; 27(2):210-213. PubMed ID: 29178146
[TBL] [Abstract][Full Text] [Related]
6. NRAS mutations are more prevalent than KIT mutations in melanoma of the female urogenital tract--a study of 24 cases from the Netherlands.
van Engen-van Grunsven AC; Küsters-Vandevelde HV; De Hullu J; van Duijn LM; Rijntjes J; Bovée JV; Groenen PJ; Blokx WA
Gynecol Oncol; 2014 Jul; 134(1):10-4. PubMed ID: 24802725
[TBL] [Abstract][Full Text] [Related]
7. Recurrent KRAS, KIT and SF3B1 mutations in melanoma of the female genital tract.
Cai YJ; Ke LF; Zhang WW; Lu JP; Chen YP
BMC Cancer; 2021 Jun; 21(1):677. PubMed ID: 34102999
[TBL] [Abstract][Full Text] [Related]
8. Molecular Alterations in Vaginal Melanomas: Report of 4 Cases and Literature Review.
Moran JMT; Fujimoto M; Iwahashi Y; Cornejo KM; Hoang MP
Am J Dermatopathol; 2021 Jan; 43(1):45-48. PubMed ID: 32739965
[TBL] [Abstract][Full Text] [Related]
9. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases.
Seifried S; Haydu LE; Quinn MJ; Scolyer RA; Stretch JR; Thompson JF
Ann Surg Oncol; 2015; 22(6):1959-66. PubMed ID: 25384702
[TBL] [Abstract][Full Text] [Related]
10. Management of vulvar and vaginal melanomas: current and future strategies.
Leitao MM
Am Soc Clin Oncol Educ Book; 2014; ():e277-81. PubMed ID: 24857113
[TBL] [Abstract][Full Text] [Related]
11. KIT pathway alterations in mucosal melanomas of the vulva and other sites.
Omholt K; Grafström E; Kanter-Lewensohn L; Hansson J; Ragnarsson-Olding BK
Clin Cancer Res; 2011 Jun; 17(12):3933-42. PubMed ID: 21680547
[TBL] [Abstract][Full Text] [Related]
12. Urethral involvement is associated with higher mortality and local recurrence in vulvar melanoma: a single institutional experience.
Modi MB; Gimotty PA; Ming ME; Jariwala N; Elenitsas R; Miller C; Chu EY; Lindner H; Moshiri AS; Schwartz LE; Lal P; Reyes MC; Elder DE; Xu X
Hum Pathol; 2020 Oct; 104():1-8. PubMed ID: 32702401
[TBL] [Abstract][Full Text] [Related]
13. KIT mutations and CD117 overexpression are markers of better progression-free survival in vulvar melanomas.
Dias-Santagata D; Selim MA; Su Y; Peng Y; Vollmer R; Chłopik A; Tell-Marti G; Paral KM; Shalin SC; Shea CR; Puig S; Fernandez-Figueras MT; Biernat W; Ryś J; Marszalek A; Hoang MP
Br J Dermatol; 2017 Nov; 177(5):1376-1384. PubMed ID: 28734009
[TBL] [Abstract][Full Text] [Related]
14. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
15. Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations.
Cosgarea I; Ugurel S; Sucker A; Livingstone E; Zimmer L; Ziemer M; Utikal J; Mohr P; Pfeiffer C; Pföhler C; Hillen U; Horn S; Schadendorf D; Griewank KG; Roesch A
Oncotarget; 2017 Jun; 8(25):40683-40692. PubMed ID: 28380455
[TBL] [Abstract][Full Text] [Related]
16. Vulvar/vaginal melanoma: an updated surveillance epidemiology and end results database review, comparison with cutaneous melanoma and significance of racial disparities.
Mert I; Semaan A; Winer I; Morris RT; Ali-Fehmi R
Int J Gynecol Cancer; 2013 Jul; 23(6):1118-25. PubMed ID: 23765206
[TBL] [Abstract][Full Text] [Related]
17. Absence of BRAF mutations in UV-protected mucosal melanomas.
Edwards RH; Ward MR; Wu H; Medina CA; Brose MS; Volpe P; Nussen-Lee S; Haupt HM; Martin AM; Herlyn M; Lessin SR; Weber BL
J Med Genet; 2004 Apr; 41(4):270-2. PubMed ID: 15060100
[TBL] [Abstract][Full Text] [Related]
18. Urethral Melanoma - Clinical, Pathological and Molecular Characteristics.
Mano R; Hoeh B; DiNatale RG; Sanchez A; Benfante NE; Reznik E; Leitao MM; Shoushtari AN; Goh A; Donat SM; Herr HW; Bochner BH; Dalbagni G; Donahue TF
Bladder Cancer; 2022; 8(3):291-301. PubMed ID: 36277327
[TBL] [Abstract][Full Text] [Related]
19. Primary malignant melanoma of the vulva--an aggressive tumor for modeling the genesis of non-UV light-associated melanomas.
Ragnarsson-Olding BK
Acta Oncol; 2004; 43(5):421-35. PubMed ID: 15360046
[TBL] [Abstract][Full Text] [Related]
20. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites.
Cohen Y; Rosenbaum E; Begum S; Goldenberg D; Esche C; Lavie O; Sidransky D; Westra WH
Clin Cancer Res; 2004 May; 10(10):3444-7. PubMed ID: 15161700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
